COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses

At the beginning of the COVID-19 pandemic, patients with immune-mediated inflammatory diseases were considered to be at high risk for SARS-CoV-2 infection and the development of severe COVID-19. Data collected over the past year, however, suggest that a diagnosis of inflammatory arthritis, psoriasis...

Descripción completa

Detalles Bibliográficos
Autores principales: Fagni, Filippo, Simon, David, Tascilar, Koray, Schoenau, Verena, Sticherling, Michael, Neurath, Markus F, Schett, Georg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397302/
https://www.ncbi.nlm.nih.gov/pubmed/34485930
http://dx.doi.org/10.1016/S2665-9913(21)00247-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397302/
https://www.ncbi.nlm.nih.gov/pubmed/34485930
http://dx.doi.org/10.1016/S2665-9913(21)00247-2

Ejemplares similares